Johnson & Johnson’s cardiovascular group continues to offset slower growth in other businesses after the healthcare giant spent more than $30 billion to buy a string of cardio companies over the past year. The cardiovascular business grew year over year by more than 26% in the third quarter, helped by the additions of Abiomed and Shockwave Medical, which J&J paid about $16.6 billion and $13.1 billion to acquire, respectively. Tim Schmid, J&J’s worldwide chairman of medtech, told investors on a Tuesday earnings call that both acquisitions are performing as expected.
Read the full article: J&J’s Recent Medtech Buys Help to Prop up Devices Unit //
Source: https://www.medtechdive.com/news/jnj-acquisitions-help-medical-device-earnings/729892